Quest Diagnostics Adds Vicky Gregg to Board of Directors
News Jul 25, 2014
Quest Diagnostics has announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective immediately, expanding the Board to 10 members.
Ms. Gregg served as the Chief Executive Officer of Chattanooga-based Blue Cross Blue Shield of Tennessee from 2003 through December 2012. Prior to being elected CEO, she served in a number of other leadership roles, including President and Chief Operating Officer.
Before that, she held a series of senior roles at Humana Health Plans. Ms. Gregg is a noted national expert in health information technology and was appointed to the U.S. National Institutes of Health Commission on Systemic Interoperability in 2004.
"During Vicky's tenure as CEO, Blue Cross Blue Shield of Tennessee substantially grew revenues, membership and market share," said Steve Rusckowski, President and CEO, Quest Diagnostics. "Her deep experience in healthcare from a payer's perspective will strengthen our Board and her insights will bolster our efforts to restore growth and drive operational excellence."
Daniel C. Stanzione, Ph.D., Chairman of the Board of Directors of Quest Diagnostics, added: "Vicky Gregg brings expertise in health policy, strategy, operations and health information technology that will be helpful to our company. We are delighted that she will serve on our Board."
A nurse by training, Vicky Gregg currently serves on the Boards of Team Health, First Horizon, TriZetto and the Electric Power Board of Chattanooga.
Previously, she served on several national boards, including America's Health Insurance Plans (Chair 2010-2011), the BlueCross BlueShield Association, the National Institute for Healthcare Management (Chair 2012), and the Healthcare Leadership Council.
Eagle-Eyed Machine Learning Algorithm Outdoes Human ExpertsNews
A new approach to machine learning enables AI to make the rules.READ MORE
First Practice Guidelines for Clinical Evaluation of Alzheimer's diseaseNews
Alzheimer’s disease experts gather in Chicago to plan guidelines for cliniciansREAD MORE
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE